Metoprolol Succinate Extended Release Tablets IP – Preslol 25 ER Tablets

PRESLOL 25 ER Tablets
Composition:- Metoprolol 25 mg Extended Release

PRESLOL 25 ER Tablets – Metoprolol Succinate Extended Release Tablets IP 25MG contains Metoprolol Succinate 25mg in an Extended Release (ER) formulation. It is a cardioselective β1-blocker that reduces heart rate, cardiac output, and blood pressure by blocking β1-adrenergic receptors in the heart. The ER formulation ensures steady drug release throughout the day, providing sustained therapeutic action with improved patient compliance. It is commonly prescribed for hypertension, angina pectoris, arrhythmias, and long-term management after myocardial infarction.

Key Points of Metoprolol Succinate Extended Release Tablets – PRESLOL 25 ER Tablets
• Sustained Release Action – Provides 24-hour coverage with once-daily dosing, ease in dosing and reduces dose frequency.
• Cardioselective Beta-Blocker – Selectively targets the heart with minimal effect on lungs and peripheral vessels.
• Effective Hypertension Control – Reduces both systolic and diastolic blood pressure consistently.
• Prevents Angina & Arrhythmias – Lowers cardiac workload, stabilizes heart rhythm, and reduces frequency of angina attacks.

Can be Prescribed by:
• Cardiologists
• General Physicians
• Internists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.